A24L (p.Ala24Leu) variant of UBQLN2 (Ubiquilin-2)
A24L (p.Ala24Leu) in UBQLN2 (Ubiquilin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The record also includes variant effect predictions and structural context.
A24L (p.Ala24Leu) variant details
- p.Ala24Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Missense
- MetaLR 0.04
- MetaSVM -1.02
- SIFT 0.04
- UniProt: Variant assessed as somatic; high impact.
- Structural context available